Physician profile
Patrick C Hsieh
NPI 1942405956
$345,063.04
in general payments reported to CMS, 2019-2025
13 companies · $35K in 2025
The $35K reported for 2025 was more than what 93% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $41K · 2021: $42K · 2022: $70K · 2023: $66K · 2024: $56K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $156K · Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $156,038.23 |
| Food and Beverage | $999.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $197,150.22 | 2021-2025 | Cd Horizon Spinal System, Mazor X System |
| Medtronic USA, INC. | $63,046.93 | 2019-2020 | |
| Nuvasive, INC. | $35,604.28 | 2019-2023 | Vuepoint |
| Zimvie INC. | $30,583.10 | 2022-2023 | |
| Highridge Medical LLC | $10,221.18 | 2024-2025 | Trelloss-C Sa |
| Globus Medical, INC. | $7,922.25 | 2024-2025 | Vuepoint, Vuepoint, Hedron Ia |
| Innovasis INC | $407.87 | 2023 | |
| Orthofix Medical, INC. | $110.34 | 2025 | Osteostrand |
| Depuy Synthes Sales INC. | $16.87 | 2021 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hsieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.